BioSpace News Archive

Deals

Retrophin Snags Cholic Acid Rights From Asklepion Pharmaceuticals in $78 Million Deal

January 12, 2015
·
4 min read
Business

Mersana Therapeutics, Inc., Takeda Pharmaceutical Co. Ltd. Expand Antibody-Drug Pact By $300 Million

January 12, 2015
·
3 min read
Drug Development

SAGE Therapeutics Initiates Phase 2a Trial Of SAGE-547 In Postpartum Depression

January 12, 2015
·
7 min read
Drug Development

Radius Announces Follow-Up On The Positive Phase 3 Top-Line Results For Its Investigational Drug Abaloparatide-SC In Postmenopausal Women With Severe Osteoporosis

January 12, 2015
·
7 min read
Drug Development

Portola Pharmaceuticals, Inc. Initiates Phase 4 Study To Support Accelerated Approval Of Andexanet Alfa -- Its Breakthrough-Designated Factor Xa Inhibitor Antidote

January 12, 2015
·
9 min read
Bio NC

Chimerix, Inc. Receives Notice Of Allowance For Brincidofovir Composition Of Matter Patent Extending Exclusivity To 2034

January 12, 2015
·
3 min read
Biotech Bay

Altos Therapeutics Receives Second Issued Patent Covering Novel Dopamine D2/D3 Antagonists For The Treatment Of Gastrointestinal Diseases

January 12, 2015
·
2 min read
Deals

Tekmira And Oncore Announce Merger Agreement To Create Leading Global Hepatitis B Virus Company

January 12, 2015
·
17 min read
BioMidwest

Centene Corporation Announces Pricing Of Notes

January 12, 2015
·
3 min read
Drug Development

DBV Technologies Announces Publication In The Journal Of Allergy And Clinical Immunology Of Data Demonstrating That Epicutaneous Immunotherapy May Influence The Natural History Of Allergy

January 12, 2015
·
5 min read